First human tests begin for promising new eczema treatment
NCT ID NCT06686797
Summary
This is an early safety study testing a new oral medicine called PF-08049820, which is being developed to treat moderate to severe eczema (atopic dermatitis). The study involves 71 healthy adult volunteers and will check for side effects, see how the body processes the medicine, and determine if food affects its absorption. This is the first step in human testing before the medicine can be studied in people who actually have eczema.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.